Biomarkers

Biomarker advancements are revolutionizing cancer care by enabling personalized treatments, improving patient outcomes, and addressing challenges in testing, access, and care coordination—offering valuable insights into the future of oncology.

Although biomarker-driven targeted therapies for gastric cancer have advanced significantly, many eligible patients are not receiving these treatments, highlighting the urgent need to overcome barriers such as insufficient biomarker testing and socioeconomic disparities.

Navigators can help patients understand genetic aspects of cancer and its treatment. Here’s how.